Heart: myocarditis in Dogs (Canis) | Vetlexicon
canis - Articles

Heart: myocarditis

ISSN 2398-2942


Introduction

  • Myocardial inflammation, infiltrate and necrosis/degeneration of adjacent myocytes.
  • Cause: classic myocarditis is related to inflammation due to exposure to either discrete external antigens such as bacteria, viruses, parasites or internal triggers such as autoimmune disease. In people, drug/toxin induced myocarditis is also recognized.
  • Signs: variable - arrhythmias to congestive heart failure (CHF) and sudden death.
  • Diagnosis: history and clinical signs (systemic illness), heart auscultation, electrocardiography, echocardiography, cardiac troponin I, endomyocardial biopsy, serology, blood culture.
  • Treatment: specific treatment against inciting element plus treatment of arrhythmia/CHF.
  • Prognosis: depends on severity and inciting agent/cause.

Presenting signs

  • Concurrent systemic illness or history of exposure to toxic substance.
  • Signs of cardiac dysfunction.
  • No pathognomonic signs.

Geographic incidence

  • In areas of world where certain infectious diseases are endemic, eg Trypanasoma cruzi (South-East USA), Rickettsia rickettsii (Rocky Mountain Spotted fever, USA), Leishmania (worldwide) and possibly Borrelia burgodorferi (Lyme's disease USA, Europe).

Age predisposition

Viral myocarditis

Cost considerations

  • Dependent on severity of myocardial involvement and ease of treatment of inciting agent.

Special risks

Pathogenesis

Etiology

Infectious causes

Viral myocarditis

Protozoal myocarditis 

Bacterial myocarditis 

Predisposing factors

General

  • Immunosuppression.
  • Debility.

Specific

  • Exposure to infectious agent or use of myocardiotoxic substances such as doxorubicin Doxorubicin.

Pathophysiology

  • Inflammation of heart muscle caused by infectious/toxic agent(s) affecting pericardium, myocytes, interstitial or vascular tissue of heart.
  • May be acute or chronic if infectious.
  • Can result in cardiac dysfunction.
  • Infection may arise locally, including valvular tissue, or be spread from distant sites, eg dental, prostate, skin, uterus, lung.
  • Infection/toxicity → toxin (local or blood borne)/immune-complex/direct invasion → vasculitis/myocyte damage → myocardial inflammation → cardiac dysfunction = arryhthmias/CHF.
  • Often concurrent signs of systemic infection/toxicity.
  • Severe systemic disease, eg GDV, IMHA - sympathetic 'storm' and release of free radicals - myocardial necrosis - arrhythmias.

Timecourse

  • May have acute (days), or chronic (months) course.
  • Acute disease may progress to a form of cardiomyopathy and eventually heart failure.

Diagnosis

Subscribe To View

This article is available to subscribers.

Try a free trial today or contact us for more information.

Treatment

Subscribe To View

This article is available to subscribers.

Try a free trial today or contact us for more information.

Prevention

Subscribe To View

This article is available to subscribers.

Try a free trial today or contact us for more information.

Outcomes

Subscribe To View

This article is available to subscribers.

Try a free trial today or contact us for more information.

Further Reading

Publications

Refereed papers

  • Recent references from PubMed and VetMedResource.
  • Ferasin L et al (2021) Infection with SARS-CoV-2 variant B.1.1.7 detected in a group of dogs and cats with suspected myocarditis. Vet Rec 189(9), e944 PubMed.